Brainstorm Cell Therapeutics

-$0.02 (-0.59%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BCLI and other stocks, options, and ETFs commission-free!

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury.

CEO
Chaim Lebovits
Employees
40
Headquarters
New York, New York
Founded
2000

BCLI Key Statistics

Market Cap
118.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
409.76K
High Today
$3.43
Low Today
$3.31
Open Price
$3.33
Volume
170.75K
52 Week High
$17.95
52 Week Low
$2.92

BCLI Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 2, Pre-Market

You May Also Like

MVP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure